摘要
Background Vascular endothelial growth factor （VEGF） is a major mediator of angiogenesis,and plays a key role in the pathogenesis of diabetic retinopathy （DR）.This study was designed to identify the possible role of VEGF gene polymorphisms in the development of DR in type 2 diabetic patients in Chinese and clarify the relationship between VEGF serum levels and the risk of DR.Methods This cross-sectional study included 1 040 Chinese subjects with type 2 diabetes mellitus.There were 372 patients diagnosed with DR in the case group and 668 patients without DR in the control group.DNA from each patient was analyzed for VEGF polymorphisms of-2578A/C （rs699947）,-1154G/A （rs1570360）,-460C/T （rs833061）,＋405C/G （rs2010963）,and ＋936C/T （rs3025039） using MassARRAY compact analyzer.The VEGF serum levels were quantified by enzyme-linked immunosorbent assay （ELISA）.Results No evidence of association was observed between-2578 A/C （rs699947）,＋405C/G （rs2010963）,＋936C/T （rs3025039）,and DR risk under stringent Bonferroni＆#39;s correction.However,VEGF serum levels were significantly higher in DR patients than those of control group.The genetic variation of VEGF polymorphisms influenced VEGF serum levels; subjects carrying the VEGF-2578 C/C （rs699947） genotype had greater VEGF serum levels than those carrying the C/A genotype and VEGF serum levels were significantly higher in CC genotype of the ＋405C/G （rs2010963） compared with those of the other genotypes.Conclusions The data did not suggest significant association between the VEGF polymorphisms and DR risk under stringent Bonferroni＆#39;s correction.However,our study indicated that DR patients have higher VEGF levels than diabetic patients without retinopathy,and-2578A/C （rs699947） and ＋405C/G （rs2010963） may be important factors in determining serum VEGF levels.
Background Vascular endothelial growth factor （VEGF） is a major mediator of angiogenesis,and plays a key role in the pathogenesis of diabetic retinopathy （DR）.This study was designed to identify the possible role of VEGF gene polymorphisms in the development of DR in type 2 diabetic patients in Chinese and clarify the relationship between VEGF serum levels and the risk of DR.Methods This cross-sectional study included 1 040 Chinese subjects with type 2 diabetes mellitus.There were 372 patients diagnosed with DR in the case group and 668 patients without DR in the control group.DNA from each patient was analyzed for VEGF polymorphisms of-2578A/C （rs699947）,-1154G/A （rs1570360）,-460C/T （rs833061）,＋405C/G （rs2010963）,and ＋936C/T （rs3025039） using MassARRAY compact analyzer.The VEGF serum levels were quantified by enzyme-linked immunosorbent assay （ELISA）.Results No evidence of association was observed between-2578 A/C （rs699947）,＋405C/G （rs2010963）,＋936C/T （rs3025039）,and DR risk under stringent Bonferroni＆#39;s correction.However,VEGF serum levels were significantly higher in DR patients than those of control group.The genetic variation of VEGF polymorphisms influenced VEGF serum levels; subjects carrying the VEGF-2578 C/C （rs699947） genotype had greater VEGF serum levels than those carrying the C/A genotype and VEGF serum levels were significantly higher in CC genotype of the ＋405C/G （rs2010963） compared with those of the other genotypes.Conclusions The data did not suggest significant association between the VEGF polymorphisms and DR risk under stringent Bonferroni＆#39;s correction.However,our study indicated that DR patients have higher VEGF levels than diabetic patients without retinopathy,and-2578A/C （rs699947） and ＋405C/G （rs2010963） may be important factors in determining serum VEGF levels.
